• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Sci Rep . Association between COVID-19 and the development of chronic kidney disease in patients without initial acute kidney injury

tetano

Editor, Senior Moderator
Sci Rep


. 2025 Mar 29;15(1):10924.
doi: 10.1038/s41598-025-96032-4. Association between COVID-19 and the development of chronic kidney disease in patients without initial acute kidney injury

I-Wen Chen[SUP] 1 2 [/SUP], Li-Chen Chang[SUP] 3 [/SUP], Chun-Ning Ho[SUP] 2 4 [/SUP], Jheng-Yan Wu[SUP] 5 [/SUP], Ya-Wen Tsai[SUP] 6 [/SUP], Chien-Ming Lin[SUP] 2 4 [/SUP], Ying-Jen Chang[SUP] 4 7 [/SUP], Kuo-Chuan Hung[SUP] 8 9 [/SUP]



Affiliations
Free article Abstract

While the association between COVID-19 and acute kidney injury (AKI) is well documented, the impact of COVID-19 on the development of advanced chronic kidney disease (CKD) remains unclear, particularly in patients without initial AKI. Using the TriNetX healthcare database, we conducted a matched cohort study comparing 141,587 COVID-19 and 141,587 influenza patients. We excluded patients with AKI within one month of infection and matched groups on demographics, comorbidities, and baseline laboratory values. The primary outcome was the incidence of advanced CKD (stages 3-5) at the 12-month follow-up. COVID-19 patients showed higher 12-month risks of advanced CKD (hazard ratio
:2.02, 95% confidence interval [CI]:1.69-2.42, p < 0.0001), AKI (HR 3.04, 95%CI:2.61-3.55, p < 0.0001), and estimated glomerular filtration rate < 60 mL/min/1.73 m[SUP]2[/SUP] (HR:3.01, 95%CI:2.74-3.30, p < 0.0001) compared to influenza patients. Subgroup analyses showed consistently elevated risks across sexes and in patients over 45 years, while younger patients did not demonstrate an increased risk of advanced CKD at the 12-month follow-up. Diabetes mellitus and hypertension have emerged as the strongest predictors of advanced CKD development. In conclusion, COVID-19 is associated with an increased risk of long-term renal dysfunction compared with influenza, suggesting the need for extended monitoring of kidney function in high-risk populations.

Keywords: Acute kidney injury; COVID-19; Chronic kidney disease; Renal function.

 
Back
Top Bottom